As of June 16, 2025, Cronos Group Inc (CRON.TO) reports a ROA (Return on Assets) of 3.52%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Cronos Group Inc's ROA (Return on Assets)
Over recent years, Cronos Group Inc's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2024-12-31 | 3.52% |
| 2023-12-31 | -6.49% |
| 2022-12-31 | -13.91% |
| 2021-12-31 | -28.34% |
| 2020-12-31 | -3.80% |
This slight upward trend highlights how Cronos Group Inc manages its efficiency in using assets to generate earnings over time.
Comparing Cronos Group Inc's ROA (Return on Assets) to Peers
To better understand Cronos Group Inc's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Cronos Group Inc (CRON.TO) | 3.52% |
| SIGA Technologies Inc (SIGA) | 24.23% |
| Corcept Therapeutics Inc (CORT) | 16.80% |
| Harmony Biosciences Holdings Inc (HRMY) | 14.51% |
| Lotus Pharmaceuticals Inc (LTUS) | 13.98% |
| Amphastar Pharmaceuticals Inc (AMPH) | 10.11% |
Compared to its competitors, Cronos Group Inc's ROA (Return on Assets) is about average compared to peers, indicating typical asset efficiency for the industry.